Julia Lainster sits down with Ivan Kairatov, a seasoned biopharma leader with deep experience in
In emergency rooms, prenatal clinics, and primary care offices alike, clinicians reach for
Diving into the world of virology, we’re thrilled to speak with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development. With a deep understanding of technology and innovation in the industry, Ivan has been at the forefront of groundbreaking discoveries.
In the rapidly advancing world of biotechnology and medicine, protein engineering stands as a cornerstone for innovation, yet it faces persistent challenges in designing proteins with precise, tailored functionalities that meet specific needs. For years, scientists have wrestled with the
Imagine a world where a doctor’s visit is just a click away, no matter where a patient resides or
In a world where breast cancer claims countless lives each year, a staggering statistic emerges:
The landscape of rare disease drug development is littered with clinical failures. For every success, countless promising compounds fail to demonstrate efficacy in late-stage trials, often due to the…
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence
Misdiagnosis is a problem facing medicine today. A significant reason for this challenge is that
Every sentence you hear arrives as an unbroken ribbon of sound, yet your mind carves it into words with split-second precision before the next syllable even lands, never waiting for a pause that does not exist. That everyday magic—effortless for a native tongue and baffling in an unfamiliar
The scale of diabetic eye screening would swamp any manual system left to grow unchecked, with more
Glioblastoma care has long run up against a biological wall that blunts even the best therapies,
